摘要:
The invention relates to a method for producing a aqueous dispersion and consists of the following steps: a) making available water and a suspending agent; b) adding and polymerising from 25.0 to 45.0 weight parts of a first compound containing A) 50.0 99.9 weight parts of alkylmethacrylate, B) 0.0-40.0 weight parts of alkylacrylate, C) 0.1-10.0 weight parts of cross-linking monomers and D) 0.0-0.8 weight parts of styrene monomers; c) adding and polymerising from 35.0 to 55.0 weight parts of a second compound containing E) 80.0-100.0 weight parts of (meth)acrylate, F) 0.05-10.0 weight parts of cross-linking monomers and G) 0.0-20.0 weight parts of styrene monomers; d) adding and polymerisation from 10.0 to 30.0 weight parts of a third compound containing H) 50.0-100.0 weight parts of alkylmethacrylate, I) 0.0-40.0 weight parts of alkylacrylate and J) 0.0-10.0 weight parts of styrene monomers. The inventive method is characterised in the following: e) each polymerisation is carried out at a temperature of >60 and
摘要:
The invention relates to a method for producing a pharmaceutical dosage form as tablets, pellets and/or in the form of an active ingredient-containing matrix, whereby the tablets, pellets and/or active ingredient-containing matrix contain a pharmaceutical active ingredient and a copolymer serving as a coating agent and/or binding agent, and optionally contain a core and pharmaceutically common additives. According to the invention, the copolymer, the pharmaceutical active ingredient, the optionally present core and/or the pharmaceutically common additives are processed using known techniques by melting, injection molding, extrusion, wet granulation, casting, dipping, spreading out, spraying on, or pressing to form tablets, pellets and/or an active ingredient-containing matrix. The inventive method is characterized in that a copolymer is used that consists of 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate and 0 to 40 wt. % ethylacrylate and, optionally, of 0 to 10 wt. % of additional vinylically copolymerizable monomers with the provision that the glass transition temperature of the copolymer is no higher than 60° C according to ISO 11357-2, Item 3.3.3. The invention also relates to the pharmaceutical dosage form produced according to this method, said copolymer and the use thereof.
摘要:
The invention relates to reactive polysols with a reactive monomer portion which is polymerized during thermal coating. The polysols exhibit good mechanical properties. A monofunctional (meth)acrylate monomer of formula (I) is used as reactive monomer component.
摘要:
The invention relates to a novel impact-resistance modifier, constructed from a core-shell 1 and a shell 2, whereby the core is plastically deformable. The invention is characterised by excellent mechanical properties obtained by a low content of impact-resistance modifier.
摘要:
The invention relates to a method for producing a bead-shaped, cross-linked hydrophilic mixed polymer which actively bonds with ligands with nucleophilic groups, by inversely bead-polymerising a monomer phase. The invention also relates to polymer support materials with a high capacity for bonding with penicillin acylase and with a lower swelling number, and to their use.
摘要:
The invention relates to a novel impact-resistance modifier, constructed from a core-shell 1 and a shell 2, whereby the core is plastically deformable. The invention is characterised by excellent mechanical properties obtained by a low content of impact-resistance modifier.
摘要:
The invention relates to a method for producing a bead-shaped, cross-linked hydrophilic mixed polymer which actively bonds with ligands with nucleophilic groups, by inversely bead-polymerising a monomer phase. The invention also relates to polymer support materials with a high capacity for bonding with penicillin acylase and with a lower swelling number, and to their use.
摘要:
The invention relates to reactive polysols with a reactive monomer portion which is polymerized during thermal coating. The polysols exhibit good mechanical properties. A monofunctional (meth)acrylate monomer of formula (I) is used as reactive monomer component.
摘要:
The invention relates to a novel impact-resistance modifier, constructed from a core-shell 1 and a shell 2, whereby the core is plastically deformable. The invention is characterised by excellent mechanical properties obtained by a low content of impact-resistance modifier.
摘要:
The invention relates to a method for producing a pharmaceutical dosage form as tablets, pellets and/or in the form of an active ingredient-containing matrix, whereby the tablets, pellets and/or active ingredient-containing matrix contain a pharmaceutical active ingredient and a copolymer serving as a coating agent and/or binding agent, and optionally contain a core and pharmaceutically common additives. According to the invention, the copolymer, the pharmaceutical active ingredient, the optionally present core and/or the pharmaceutically common additives are processed using known techniques by melting, injection molding, extrusion, wet granulation, casting, dipping, spreading out, spraying on, or pressing to form tablets, pellets and/or an active ingredient-containing matrix. The inventive method is characterized in that a copolymer is used that consists of 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate and 0 to 40 wt. % ethylacrylate and, optionally, of 0 to 10 wt. % of additional vinylically copolymerizable monomers with the provision that the glass transition temperature of the copolymer is no higher than 60 DEG C according to ISO 11357-2, Item 3.3.3. The invention also relates to the pharmaceutical dosage form produced according to this method, said copolymer and the use thereof.